Clinical trial
Paclitaxel in Treating Patients With Early-Stage Bladder Cancer
NCT00002917 · Mary Babb Randolph Cancer Center at West Virginia University Hospitals, Other · Completed
Key facts
| NCT number | NCT00002917 |
|---|---|
| Title | Paclitaxel in Treating Patients With Early-Stage Bladder Cancer |
| Official title | A PHASE I/II INSTITUTIONAL STUDY OF INTRAVESICAL TAXOL (PACLITAXEL) INSTILLATION FOR THE TREATMENT OF SUPERFICIAL BLADDER CANCER |
| Lead sponsor | Mary Babb Randolph Cancer Center at West Virginia University Hospitals, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Bladder Cancer |
| Intervention type | Drug |
| Interventions | paclitaxel |
| Start date | Nov 1, 1996 |
| Completion | May 1, 2004 |
| First posted | May 26, 2004 |
| Last update posted | May 15, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: